Leadership Change

The appointment of a merger-savvy industry veteran to Oregon Mutual's board signals a calculated move to navigate consolidation and technological disruption.

With wins from the Cerebras and SpaceX IPOs, Open Doors Partners hires Ravi Chiruvolu to deepen its expertise in a pivotal moment for private markets.

The appointment of a top lawyer at a key compliance firm reveals how technology and human expertise are being fused to tame our most complex social safety nets.

With a strategic CFO and a powerhouse board nominee, ONE Nuclear is fortifying its governance as it prepares for a Nasdaq listing and a hybrid energy future.

A biometrics CRO appoints a physician-AI strategist, signaling a pivotal shift from tech hype to the deep, regulated integration of AI in drug development.

With the strategic hire of growth guru Jim Garrity, Symmatrics signals a pivotal shift from theoretical promise to market dominance in quantum security.

While many firms poach top talent, Markwins Beauty Brands cultivates it. An inside look at how their strategy of promoting women from within is not just about culture, but a masterclass in building a corporate dynasty.

A top exec's move from a device giant to a drug startup signals a major shift. Charles Anderson analyzes why hardware's limits in fighting infection are now biotech's biggest opportunity.

Coultreon Biopharma's strategic hire of Dr. Prista Charuworn signals a major push to advance its novel SIK3 inhibitor in the crowded autoimmune market.

TDECU's historic appointment of its first female Chair, a tech law expert, and two other industry titans is more than a shuffle—it's a growth signal.

As the at-home diagnostics market heats up, Aptitude Medical Systems doubles down on its leadership, appointing a co-CEO to accelerate its commercial future.

As the 25th anniversary of 9/11 approaches, one foundation isn't just remembering. It's engineering a future for memory itself using digital archives.

Brazil's EBANX is decentralizing its command structure, embedding top executives worldwide. Is this the blueprint for conquering emerging payment markets?

The women-owned, B-Corp certified distillery from Crested Butte, CO, has appointed a star-studded advisory board to navigate its next stage of global growth.

Facing financial turbulence, non-prime lender goeasy appoints Mark Snyder to unify risk and data, betting his AI expertise can navigate a volatile market.

JLL Partners' acquisition of Life Couriers and the appointment of a new CEO signal a major bet on the future of time-critical healthcare logistics.

Alorica appoints veteran insiders to lead its massive Philippine operations, signaling a dual strategy of leveraging human talent and advanced AI to lead the CX race.

With a new CEO, a leaner budget, and crucial data on the horizon for its brain and obesity drugs, Neumora is navigating a pivotal phase of growth.

With fully funded facilities and a US Army pact, REalloys is building a non-Chinese magnet supply chain. But can its strategic wins outweigh a $37M loss?

With regulatory winds at its back in the US and EU, Cibus is pushing to commercialize its non-GMO tech. Can new leadership turn R&D into revenue before cash runs out?